Comment on: Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease: Reply

Journal Article Corrected proof Comment on: Antibody predictors of mortality and lung function trends in myositis spectrum interstitial lung disease: Reply Get access Jennifer Hannah, Jennifer Hannah Department of Academic Rheumatology, King's College London, London, UKDepartment of Rheumatology, King's College Hospitals NHS Trust, London, UK Correspondence to: Jennifer Hannah, Department of Academic Rheumatology, King's College London, Weston Education Centre, 10 Cutcombe Road, London SE5 9RJ, UK. E-mail: Jennifer.1.hannah@kcl.ac.uk https://orcid.org/0000-0002-3491-6653 Search for other works by this author on: Oxford Academic PubMed Google Scholar Elisabetta A Renzoni, Elisabetta A Renzoni Interstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UKMargaret Turner Warwick Centre for Fibrosing Lung Disease, National Heart and Lung Institute, Imperial College London, London, UK Search for other works by this author on: Oxford Academic PubMed Google Scholar Patrick Gordon Patrick Gordon Department of Academic Rheumatology, King's College London, London, UKDepartment of Rheumatology, King's College Hospitals NHS Trust, London, UKInterstitial Lung Disease Unit, Royal Brompton and Harefield Clinical Group, Guy's and St Thomas' NHS Foundation Trust, London, UK Search for other works by this author on: Oxford Academic PubMed Google Scholar Rheumatology, keae105, https://doi.org/10.1093/rheumatology/keae105 Published: 09 February 2024 Article history Accepted: 24 January 2024 Published: 09 February 2024 Corrected and typeset: 24 February 2024